Literature DB >> 16784915

Effect of external counterpulsation on plasma nitric oxide and endothelin-1 levels.

Mateen Akhtar1, Gui-Fu Wu, Zhi-Min Du, Zhen-Sheng Zheng, Andrew D Michaels.   

Abstract

Enhanced external counterpulsation (EECP) significantly augments diastolic blood flow and has been postulated to improve endothelial function by increased shear stress. We examined the effects of EECP on plasma nitric oxide and endothelin-1 (ET-1) levels. Plasma nitrate and nitrite (NOx) and ET-1 levels were measured serially in 13 patients with coronary artery disease who received 1-hour daily treatments of EECP over 6 weeks. During the course of EECP therapy, plasma NOx progressively increased and plasma ET-1 progressively decreased. After 36 hours of EECP, there was a 62 +/- 17% increase in plasma NOx compared with baseline (43.6 +/- 4.3 vs 27.1 +/- 2.6 micromol/L, p <0.0001) and a 36 +/- 8% decrease in plasma ET-1 (76.7 +/- 9.5 vs 119.5 +/- 8.5 pg/L, p <0.0001). At 3 months after completion of EECP, NOx remained 12 +/- 11% above baseline (p = 0.002), and ET-1 remained 11 +/- 10% below baseline (p = 0.0068). Our data provides neurohormonal evidence to support the hypothesis that EECP improves endothelial function.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16784915     DOI: 10.1016/j.amjcard.2006.01.053

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  22 in total

1.  Enhanced external counterpulsation improves peripheral artery flow-mediated dilation in patients with chronic angina: a randomized sham-controlled study.

Authors:  Randy W Braith; C Richard Conti; Wilmer W Nichols; Calvin Y Choi; Matheen A Khuddus; Darren T Beck; Darren P Casey
Journal:  Circulation       Date:  2010-10-04       Impact factor: 29.690

Review 2.  Enhanced external counterpulsation for ischemic heart disease: a look behind the curtain.

Authors:  Randy W Braith; Darren P Casey; Darren T Beck
Journal:  Exerc Sport Sci Rev       Date:  2012-07       Impact factor: 6.230

3.  Effects of enhanced external counterpulsation on arterial stiffness and myocardial oxygen demand in patients with chronic angina pectoris.

Authors:  Darren P Casey; Darren T Beck; Wilmer W Nichols; C Richard Conti; Calvin Y Choi; Matheen A Khuddus; Randy W Braith
Journal:  Am J Cardiol       Date:  2011-03-17       Impact factor: 2.778

Review 4.  Importance of hemodynamic forces as signals for exercise-induced changes in endothelial cell phenotype.

Authors:  M Harold Laughlin; Sean C Newcomer; Shawn B Bender
Journal:  J Appl Physiol (1985)       Date:  2007-12-06

5.  Effect of Enhanced External Counter Pulsation Treatment on Aortic Blood Pressure, Arterial Stiffness and Ejection Fraction in Patients with Coronary Artery Disease.

Authors:  Ramasamy Subramanian; Sushma Nayar; Chokkalingam Meyyappan; N Ganesh; Arumugam Chandrakasu; Pradeep G Nayar
Journal:  J Clin Diagn Res       Date:  2016-10-01

6.  Enhanced external counterpulsation improves endothelial function and exercise capacity in patients with ischaemic left ventricular dysfunction.

Authors:  Darren T Beck; Jeffrey S Martin; Darren P Casey; Joseph C Avery; Paloma D Sardina; Randy W Braith
Journal:  Clin Exp Pharmacol Physiol       Date:  2014-09       Impact factor: 2.557

7.  Exercise-induced Signals for Vascular Endothelial Adaptations: Implications for Cardiovascular Disease.

Authors:  Nathan T Jenkins; Jeffrey S Martin; M Harold Laughlin; Jaume Padilla
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-08-01

Review 8.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

Review 9.  Treatment of refractory angina in patients not suitable for revascularization.

Authors:  Timothy D Henry; Daniel Satran; E Marc Jolicoeur
Journal:  Nat Rev Cardiol       Date:  2013-12-24       Impact factor: 32.419

10.  Enhanced external counter pulsation in treatment of refractory angina pectoris: two year outcome and baseline factors associated with treatment failure.

Authors:  André Erdling; Susanne Bondesson; Thomas Pettersson; Lars Edvinsson
Journal:  BMC Cardiovasc Disord       Date:  2008-12-18       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.